Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Danavorexton by Takeda Pharmaceutical for Type 1 Narcolepsy (Narcolepsy with Cataplexy): Likelihood of Approval
Danavorexton is under clinical development by Takeda Pharmaceutical and currently in Phase I for Type 1 Narcolepsy (Narcolepsy with Cataplexy)....